Concord Medical Services Holdings Limited (CCM)
NYSE: CCM · Real-Time Price · USD
7.81
-0.39 (-4.76%)
At close: May 15, 2025, 4:00 PM
7.81
0.00 (0.00%)
After-hours: May 15, 2025, 4:10 PM EDT
CCM Revenue
In the year 2024, Concord Medical Services Holdings had annual revenue of 383.96M CNY, down -28.55%. Concord Medical Services Holdings had revenue of 165.15M in the half year ending December 31, 2024, a decrease of -49.62%.
Revenue (ttm)
383.96M CNY
Revenue Growth
-28.55%
P/S Ratio
0.65
Revenue / Employee
645,304 CNY
Employees
595
Market Cap
33.91M USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 383.96M | -153.45M | -28.55% |
Dec 31, 2023 | 537.40M | 65.32M | 13.84% |
Dec 31, 2022 | 472.09M | -13.55M | -2.79% |
Dec 31, 2021 | 485.63M | 262.62M | 117.76% |
Dec 31, 2020 | 223.01M | 24.65M | 12.43% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
CCM News
- 20 days ago - Concord Medical Files Annual Report on Form 20-F for Fiscal 2024 - PRNewsWire
- 4 months ago - Concord Medical Announces Result of 2024 Annual General Meeting - PRNewsWire
- 5 months ago - Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate - PRNewsWire
- 6 months ago - Concord Medical Schedules 2024 Annual Meeting of Shareholders - PRNewsWire
- 8 months ago - Concord Medical Reports Financial Results for the First Half of 2024 - PRNewsWire
- 8 months ago - Canagold Completes Resource Expansion Drilling Program at New Polaris with Additional Strong Mineralization Intercepts - Business Wire
- 8 months ago - Concord Medical Announces Obtaining Large Medical Equipment Procurement License for Its Proton Therapy Equipment - PRNewsWire
- 9 months ago - Canagold Continues to Intercept Strong Mineralization in Resource Expansion Drilling Program at New Polaris - Business Wire